海量图书期刊资源,随时随地畅享阅读乐趣
Guideline for borderline personality disorderHuttegger, Simon M.; Skyrms, Brian; Zollman, Kevin J. S. · PharmacoEconomics & Outcomes News · 2013
Probe and Adjust in Information Transfer GamesHuttegger, Simon M.; Skyrms, Brian; Zollman, Kevin J. S. · Erkenntnis · 2014
UTIs have high economic and QOL burdenHuttegger, Simon M.; Skyrms, Brian; Zollman, Kevin J. S. · PharmacoEconomics & Outcomes News · 2013
NICE U-turns on omalizumab for asthmaHuttegger, Simon M.; Skyrms, Brian; Zollman, Kevin J. S. · PharmacoEconomics & Outcomes News · 2013
Rifampicin cost-effective option for LTBI controlHuttegger, Simon M.; Skyrms, Brian; Zollman, Kevin J. S. · PharmacoEconomics & Outcomes News · 2013
Pregabalin less costly in axial radiculopathy in SpainHuttegger, Simon M.; Skyrms, Brian; Zollman, Kevin J. S. · PharmacoEconomics & Outcomes News · 2013
Costs for new drugs could be lower, says GSK bossHuttegger, Simon M.; Skyrms, Brian; Zollman, Kevin J. S. · PharmacoEconomics & Outcomes News · 2013
Aztreonam tops tobramycin in CFPharmacoEconomics & Outcomes News · 2012
Warfarin prophylaxis justified in nonvalvular AFPharmacoEconomics & Outcomes News · 1998
Antiretrovirals in HIV infectionPharmacoEconomics & Outcomes News · 1999
Fidaxomicin value for money&NA; · PharmacoEconomics & Outcomes News · 2012
Diclofenac&NA; · PharmacoEconomics & Outcomes News · 2006
SMC accepts use of IluvienFarash, Mohammad Sabzinejad; Attari, Mahmoud Ahmadian · PharmacoEconomics & Outcomes News · 2014
Getting value from health insurance plansPharmacoEconomics & Outcomes News · 2014
Screening and decolonisation ofS.PharmacoEconomics & Outcomes News · 2014